SAHPRA and the Pfizer/Biontech Comirnaty Vaccine

16 Mar SAHPRA and the Pfizer/Biontech Comirnaty Vaccine

Posted at 15:21h in News & Updates, Press Releases by Ntokozo Msiza

16 March 2021

SAHPRA has approved the Section 21 application for the Pfizer/Biontech Comirnaty Vaccine.

Download PDF

Tags:

BIONTECH, COMIRNATY, Covid-19, PFIZER, SAHPRA, vaccine

Facebook Feed

1 day ago

SAHPRA Statement – Update on Sisonke Phase 3B Implementation Study -

Latest News:

SAHPRA has engaged with the Sisonke Phase 3B Implementation Study team and Janssen Pharmaceutica. The focus of the engagement was on the safety data reported from the Sisonke study, ... See more

SAHPRA, together with its scientific expert committees, has recently reviewed the data from the Sisonke Phase 3b implementation study.

View on facebook

5 days ago

SAHPRA Statement – Update on Sisonke Phase 3B Implementation Study -

Press release:

SAHPRA, together with its scientific expert committees, has recently reviewed the data from the Sisonke Phase 3b implementation study. This study involves the administration of the ... See more

SAHPRA, together with its scientific expert committees, has recently reviewed the data from the Sisonke Phase 3b implementation study.

View on facebook

5 days ago

National Department of Health (South Africa)

Minister of Health, Dr Zweli Mkhize today announced the temporary suspension of JnJ vaccine following FDA’s similar decision of Johnson and Johnson vaccine rollout in the United States #vaccine #VaccineRolloutSA ... See more

View on facebook

6 days ago

Regulatory Compliance and overseeing Illicit medicines and products

Watch: Ms Daphney Fafudi, Regulatory Compliance manager at SAHPRA, discusses Regulatory Compliance and overseeing Illicit medicines and products.

Ms Daphney Fafudi, Regulatory Compliance manager at SAHPRA, discusses Regulatory Compliance and overseeing Illicit medicines and products.

View on facebook

1 week ago

SAHPRA will be partnering with Bio Africa in hosting a webinar that will focus on the South African landscape and regulatory processes of IKS, Medical Cannabis and Natural Products which will help ... See more

View on facebook

1 week ago

SAHPRA Statement- High Court Order - Ivermectin - SAHPRA

Press release:

On 6 April 2021 the Pretoria High Court issued a court order pertaining to four cases that were brought against SAHPRA and the Minister of Health regarding access to Ivermectin for ... See more

9 April 2021 On 6 April 2021 the Pretoria High Court issued a court order pertaining to four cases that were brought against SAHPRA and the Minister of Health regarding access to Ivermectin for use ... See more

View on facebook

1 week ago

The Government Communication and Information System in partnership with the Department of Science and Innovation, and the national Press Club will be hosting a webinar on the role of scientific ... See more

View on facebook

1 week ago

What SAHPRA does

Watch: The SAHPRA CEO discusses the mandate of SAHPRA

The SAHPRA CEO discusses the mandate of SAHPRA

View on facebook

1 week ago

Vaccines and their approval

Watch: SAHPRA CEO unpacks the process of vaccine approval

SAHPRA CEO unpacks the process of vaccine approval

View on facebook

2 weeks ago

SAHPRA registers Covid-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) with conditions

Latest News:

The South African Health Products Authority (SAHPRA) registered the Covid-19 Vaccine Janssen on 31 March 2021. The registration was done in terms of Section 15(6a) of the Medicines and ... See more

The South African Health Products Authority (SAHPRA) registered the Covid-19 Vaccine Janssen on 31 March 2021.

View on facebook

« ‹ 1 of 4 › »

Twitter Feed

SAHPRAFollow

Retweet on Twitter SAHPRA Retweeted

BIO Africa @BioAfricaCON·

8 Apr

Join our webinar: Navigating South Africa’s Cannabis Future as we focus on the South African landscape and regulatory processes which will help navigate South Africa’s Cannabis Future and unlock our potential.

Click the link below to register:

https://lnkd.in/d_m2Sj9
#Cannabis

Reply on Twitter 1380127488156651524 Retweet on Twitter 13801274881566515245 Like on Twitter 13801274881566515242 Twitter 1380127488156651524

16 Mar SAHPRA and the Pfizer/Biontech Comirnaty Vaccine

Tags:

SAHPRA Statement – Update on Sisonke Phase 3B Implementation Study

Statement by the Minister of Health, Dr Zwelini Mkhize, on the FDA’s Temporary Suspension of Johnson and Johnson vaccine rollout in the United States.

CONTACT US

Quick Menu

I want to..

Newsletter Subscription

Follow us